Omnicell Announces Third Quarter 2026 Financial Results
Omnicell delivered Q3 2026 revenue of $308 million, down 1% year-over-year, but revenue and profitability both exceeded the high end of prior guidance. GAAP EPS doubled to $0.24 from $0.12 a year ago, while non-GAAP EPS rose to $0.58 from $0.51 and non-GAAP EBITDA reached $45 million on margin expansion and cost discipline. The company raised full-year 2026 non-GAAP EBITDA guidance to $187M-$193M and non-GAAP EPS to $2.48-$2.56, tightened revenue and ARR ranges, and reiterated product bookings guidance of $425M-$560M.
Key figures
- Eps
- 0.24
- Revenue
- 307851000
- Guidance
- FY26 total revenues $1.225B-$1.231B; non-GAAP EBITDA raised to $187M-$193M; non-GAAP EPS raised to $2.48-$2.56; ARR tightened to $660M-$670M; product bookings reiterated at $425M-$560M. Q4: revenue $295M-$301M, non-GAAP EBITDA $30M-$36M, non-GAAP EPS $0.41-$0.49
- Revenue Yoy
- -1%
- Total debt
- 169000000
- Non gaap eps
- 0.58
- Non gaap fcf
- 19947000
- Gaap net income
- 11044000
- Non gaap ebitda
- 44931000
- Non gaap net income
- 27039000
- Operating cash flow
- 33052000
- Cash and equivalents
- 314856000
- Revolver availability
- 350000000
- Non gaap ebitda yoy prior
- 41132000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.